Operating Lease, Right-of-Use Asset of Mirum Pharmaceuticals, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mirum Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Mirum Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $8,500,000, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Mirum Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,500,000 -$635,000 -7% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $8,946,000 +$187,000 +2.1% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $7,663,000 +$6,983,000 +1027% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $8,675,000 +$7,391,000 +576% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $9,135,000 +$7,707,000 +540% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $8,759,000 +$7,145,000 +443% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $680,000 -$607,000 -47% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,284,000 -$147,000 -10% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $1,428,000 +$174,000 +14% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $1,614,000 +$1,314,000 +438% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $1,287,000 -$181,000 -12% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $1,431,000 -$138,000 -8.8% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $1,254,000 -$410,000 -25% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $300,000 -$1,458,000 -83% 30 Jun 2022 10-K 08 Mar 2023 2022 FY
Q1 2022 $1,468,000 -$386,000 -21% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $1,569,000 -$380,000 -19% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 $1,664,000 -$365,000 -18% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,758,000 -$349,000 -17% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $1,854,000 -$426,000 -19% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,949,000 -$412,000 -17% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q3 2020 $2,029,000 +$1,088,000 +116% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $2,107,000 +$1,138,000 +117% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $2,280,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $2,361,000 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $941,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $969,000 30 Jun 2019 10-Q 28 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.